Although in addition to TAM, bone marrow is the origin of several other immune cell types, we already demonstrated that Cav-2 deficient TAMs rather than CD4 and CD8 T cells initiate anti-tumor cascade. The gene discussed is CD8A; the disease is neoplasm.